Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Douglas (Doug) A. Simonetto, M.D., studies complications of cirrhosis and noncirrhotic portal hypertension, with a focus on ascites and hepatorenal syndrome, outcomes and management of alcohol-associated liver disease, and telomere biology disorders. He is a lead investigator in multiple national phase 2 and 3 clinical trials and he conducts translational studies and artificial intelligence (AI)-enabled outcomes research.
Dr. Simonetto's research enables the discovery of novel tools and therapies urgently needed for prevention and management of complications of cirrhosis and alcohol-associated hepatitis.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.